1. NSF Minority Faculty Development Workshop Alexis Bakos, PhD, MPH, RN,C Chief, Diversity Training Branch Center to Reduce Cancer Health Disparities, NCI OPPORTUNITIES FOR TRAINEES TO PROMOTE DIVERSITY March 23, 2010

2. HSUndergradPredoctoralPostdoctoral Junior Investigator R25T: Prevention and Control Clinical Oncology Training Grants: K12 Transition Career: K22 NRSA Fellowships: F31 and T32 S Career Awards K01 K08 K23 Cancer Center Grant: P30 SPORE: P50 Translational Cancer Center: P30 MD/POR R01R01 R 03 R 21 Continuing Umbrella of Research Experiences Diversity Supplements Supplements to the CURE: Career Development

3. Supplement Eligibility Eligible Individuals Ethnic and/or racial minorities Socio-economically disadvantaged groups First generation college graduates Individuals with disabilities Must be US Citizen or permanent resident Eligible Grants ■ NCI grants

4. Receipt of Supplement Applications by the NCI ■ Application Receipt: Two Cycles ■ October 1 through December 1 ■ March 1 through May 1 ■ Notice of Award: Office of Grants Administration

5. Research Supplements to Promote Diversity in Health Related Research ■Available for every career level e.g. High School through Junior faculty ■ Provides up to five years of support ■ * For T32, R25T, and K12 the supplement is awarded after slots are filled http://grants.nih.gov/grants/guide/pa-files/PA-08-190-html

6. Supplements to Promote Reentry into Biomedical and Behavioral Research Careers Available for individuals who want to reestablish active research careers Provides up to 3 years of support Period of career interruption is 1 to 8 years Candidate must have a doctoral degree Support for salary, fringe benefits, supplies and travel http://grants.nih.gov/grants/guide/pa-files/PA-08-191.html

7. Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research Mechanism: R21 (PAR-09-162) Purpose: To increase the diversity of the research workforce by supporting investigators from diverse populations in the area of basic cancer research. Direct Cost: $275,000 for 2 years Receipt Dates: Nov 23 rd and June 23 rd

8. Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities Mechanism: R21 (PAR-09-160) Purpose: To promote basic cancer research expertise in cancer health disparities Direct Cost: $275,000 for 2 yrs Receipt Date: Nov 23 rd and June 23 rd

9. Basic Cancer Research in Cancer Health Disparities Mechanism: U01 (PAR-09-161) Cooperative agreement FOA to conduct basic research into the causes and treatment of cancer health disparities  New methodologies  Secondary data analyses  Innovative mechanistic studies $250,000/yr for up to 5 yrs Receipt Date: Nov 23 rd and June 23rd

10. Office of Technology & Industrial Relations (OTIR) Innovative Technology Development for Cancer Research Mechanism R21 ( RFA-CA-10-005) Feasibility studies on early stage development (i.e., at their conceptual stage where feasibility has not been established) of cancer-relevant technologies in the area of CA biology, prevention, diagnosis, treatment, epidemiology & cancer health disparities Up to $500,000 over 3 yr period Receipt Date: May 27 and Sept. 30, 2010

11. Office of Technology & Industrial Relations (OTIR) Application & Early Stage Development of Emerging Technology in Cancer Research Mechanism: R21 (RFA-CA-10-003) Feasibility studies on emerging cancer-relevant technologies (i.e., has passed the initial development stage but hasn’t been evaluated within the context of its intended use) in the area of CA biology, prevention, diagnosis, treatment, epidemiology & cancer health disparities Up to $275,000 direct costs over 2 yrs Receipt Date: May 27 and Sept. 30, 2010

12. Office of Technology & Industrial Relations (OTIR) Innovative & Early-Stage Development of Emerging Technologies in Biospecimen Science Mechanism R21 (RFA-CA-10-001) Early stage studies that develop technologies capable of interrogating &/or maximizing the quality & utility of biospecimens Up to $275,000 direct costs over 2 yrs Receipt Date: May 27 and Sept. 30, 2010

13. ■ Creates a pipeline of diverse cancer investigators ■ Investigators become mentors Manuel Penichet, M.D., Ph.D. Dr. Penichet and trainees Example: Manuel Penichet, UCLA Recipient of: *Diversity Supplement *K award *R01s

14. For Supplements Peter Ogunbiyi: ogunbiyp@mail.nih.gov  For R21 & U01 Funding Opportunities  Anil Wali: walia@mail.nih.gov  For OTIR Funding Opportunities  LeeAnn Bailey: baileyl@mail.nih.gov Main Office: 301-496-7344 DTB Contacts